Centers & Institutes
The centers and institutes at Texas A&M University College of Medicine allow for focused discovery in key areas of health research and implementation. Each group specializes in meaningful approaches to effecting change and advancing basic and clinical research.
Research Centers & Institutes
Center for Airborne Pathogen Research and Imaging
The Center for Airborne Pathogen Research and Imaging (CAPRI) is a multidisciplinary, multi-institutional organization that combines the expertise of researchers who investigate pathogens that are principally transmitted via an aerosol route.
Cardiovascular Research Institute
The Cardiovascular Research Institute fosters communication and collaboration among faculty involved in cardiovascular research, education and training. The major objective of this institute is to discover and disseminate new knowledge about the heart, blood vessels and lymphatics in normal and disease states.
Clinical Science and Translational Research Institute
The Clinical Science and Translational Research (CSTR) Institute is a multi-institutional initiative of Texas A&M University and Health Science Center, and their affiliates, in partnership with Houston Methodist Hospital and Research Institute, to promote the highest quality clinical and translational research across Texas A&M and its partner institutions and train the next generation of researchers capable of expediting the application of biomedical advances into patient care and improved population health.
Texas A&M Institute for Regenerative Medicine
The Texas A&M Institute for Regenerative Medicine (IRM) was established in August 2008 as a joint venture between the Texas A&M College of Medicine, Scott & White Hospital (currently Baylor Scott & White Hospital), and the Temple Bioscience District. The goal of the institute is to bridge the gap between basic science and clinical translation in the field of regenerative medicine and experimental cell therapeutics. Through active collaboration between basic scientists and clinicians in Central Texas, the IRM hopes to tackle the ambitious task of discovering novel therapies for intractable diseases to relieve human suffering.